TCRβ chain influences but does not solely control autoreactivity of Vα14J281T cells

被引:42
作者
Gui, M [1 ]
Li, J [1 ]
Wen, LJ [1 ]
Hardy, RR [1 ]
Hayakawa, K [1 ]
机构
[1] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
关键词
D O I
10.4049/jimmunol.167.11.6239
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD1d-dependent accumulation of ap T cells bearing a canonical V alpha 14J alpha 281 alpha -chain (V alpha 14(+) T cells) is thought to model positive selection of lipid-specific T cells, based on their ability to recognize CD1d-presented self glycolipid(s). However, it has been difficult to demonstrate self ligand specificity in this system, as most Va14(+) T cells do not exhibit significant autoreactivity despite high reactivity to alpha -galactosylceramide presented by CD1d (alpha -GalCer/CD1d). To assess the role of TCR beta chain in determining the alpha -GalCer/CD1d vs autoreactive specificity of V alpha 14(+) T cells, we conducted TCR alpha or TCR beta chain transduction experiments. In this study we demonstrate, by combining different TCR beta chains with the V alpha 14 alpha -chain in retrovirally transduced T cell lines, that the Va14 alpha -chain plays a primary role, necessary but not sufficient for imparting a-GalCer/CD1d recognition. beta -Chain usage alone is not the sole factor that controls the extent of autoreactivity in Va14(+) T cells, since transduction of TCR alpha beta chains from a high CD1d autoreactive Va14(+) T cell line conferred the alpha -GalCer/CD1d specificity without induction of autoreactivity. Thus, heterogeneity of Va14(+) T cell reactivity is due to both beta -chain diversity and control mechanism(s) beyond primary TCR structure.
引用
收藏
页码:6239 / 6246
页数:8
相关论文
共 38 条
[1]   THE IMMUNOBIOLOGY OF T-CELLS WITH INVARIANT GAMMA-DELTA ANTIGEN RECEPTORS [J].
ALLISON, JP ;
HAVRAN, WL .
ANNUAL REVIEW OF IMMUNOLOGY, 1991, 9 :679-705
[2]  
Barber DF, 1998, J IMMUNOL, V161, P11
[3]   Mouse CD1-specific NK1 T cells: Development, specificity, and function [J].
Bendelac, A ;
Rivera, MN ;
Park, SH ;
Roark, JH .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :535-562
[4]   A SUBSET OF CD4(+) THYMOCYTES SELECTED BY MHC CLASS-I MOLECULES [J].
BENDELAC, A ;
KILLEEN, N ;
LITTMAN, DR ;
SCHWARTZ, RH .
SCIENCE, 1994, 263 (5154) :1774-1778
[5]   POSITIVE SELECTION OF MOUSE NK1(+) T-CELLS BY CD1-EXPRESSING CORTICAL THYMOCYTES [J].
BENDELAC, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (06) :2091-2096
[6]   CD1 RECOGNITION BY MOUSE NK1(+) T-LYMPHOCYTES [J].
BENDELAC, A ;
LANTZ, O ;
QUIMBY, ME ;
YEWDELL, JW ;
BENNINK, JR ;
BRUTKIEWICZ, RR .
SCIENCE, 1995, 268 (5212) :863-865
[7]   In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers [J].
Benlagha, K ;
Weiss, A ;
Beavis, A ;
Teyton, L ;
Bendelac, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (11) :1895-1903
[8]   POSITIVE SELECTION OF V-BETA-8+CD4-8- THYMOCYTES BY CLASS-I MOLECULES EXPRESSED BY HEMATOPOIETIC-CELLS [J].
BIX, M ;
COLES, M ;
RAULET, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (03) :901-908
[9]   ENZYMATIC DEFECT IN FABRYS DISEASE - CERAMIDETRIHEXOSIDASE DEFICIENCY [J].
BRADY, RO ;
GAL, AE ;
BRADLEY, RM ;
MARTENSS.E ;
WARSHAW, AL ;
LASTER, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1967, 276 (21) :1163-&
[10]   Clinical features of and recent advances in therapy for Fabry disease [J].
Brady, RO ;
Schiffmann, R .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (21) :2771-2775